PETER NIXON, MD
Ophthalmology Physician · AUSTIN, TX
Individual Active NPI 1467438531
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,516 | 33,539 | $20,878,116 | $7,049,799 | $5,566,681 |
| 2023 | 1,591 | 22,673 | $17,738,493 | $6,577,701 | $5,175,649 |
| 2022 | 1,739 | 18,412 | $14,651,811 | $6,406,919 | $5,038,438 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 8,280 | $229 | $182 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 6,960 | $108 | $86 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 4,305 | $148 | $118 |
| 92134 | Imaging of retina | 3,538 | $41 | $31 |
| 67028 | Injection of drug into eye | 2,764 | $136 | $103 |
| J0178 | Injection, aflibercept, 1 mg | 2,594 | $825 | $657 |
| J0177 | Injection, aflibercept hd, 1 mg | 1,408 | $332 | $264 |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 695 | $170 | $133 |
| 92014 | Established patient complete exam of visual system | 647 | $130 | $92 |
| 92250 | Photography of the retina | 550 | $38 | $28 |
| 92012 | Established patient problem focused exam of visual system | 250 | $93 | $67 |
| 92004 | New patient complete exam of visual system | 234 | $155 | $109 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | M4400 | TX |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | M4400 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Texas
- NPI 1700085248
- NPI 1245175801
- NPI 1699126425
- NPI 1245437524
- NPI 1467147793
- NPI 1992708242
- NPI 1255795217
- NPI 1427615426
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.